Cargando…

Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis

BACKGROUND: The prognostic value of circulating tumor cells (CTCs) in colorectal cancer (CRC) patients and their value in predicting tumor response to chemotherapy are controversial. The aim of this meta-analysis was to assess the prognostic and predictive value of CTCs in CRC patients treated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xuanzhang, Gao, Peng, Song, Yongxi, Sun, Jingxu, Chen, Xiaowan, Zhao, Junhua, Liu, Jing, Xu, Huimian, Wang, Zhenning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302148/ https://www.ncbi.nlm.nih.gov/pubmed/25519477 http://dx.doi.org/10.1186/1471-2407-14-976

Ejemplares similares

Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer
por: Huang, Xuanzhang, et al.
Publicado: (2015)

Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials
por: Sun, Jingxu, et al.
Publicado: (2012)

Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis
por: Sun, Jingxu, et al.
Publicado: (2016)

Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis
por: Sun, Jingxu, et al.
Publicado: (2013)

Predicting the effect of 5‐fluorouracil–based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles
por: Chen, Quan, et al.
Publicado: (2020)

The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer
por: Fu, Yu, et al.
Publicado: (2021)

Clinicopathologic characteristics and prognosis of Borrmann type IV gastric cancer: a meta-analysis
por: Luo, Yifan, et al.
Publicado: (2016)

Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis
por: Yang, Yuchong, et al.
Publicado: (2016)

Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers
por: Sun, Jingxu, et al.
Publicado: (2014)

The Efficacy and Toxicity of Paclitaxel Plus S-1 Compared With Paclitaxel Plus 5-Fu for Advanced Gastric Cancer: A PRISMA Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Liu, Huan, et al.
Publicado: (2014)

Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis
por: Wu, Zhonghua, et al.
Publicado: (2017)

Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis
por: Chen, Xiaowan, et al.
Publicado: (2016)

Do Patients with Second Primary Colorectal Cancer Hold the Similar Prognosis and Therapeutic Benefits as Those with Initial Primary Colorectal Cancer?
por: Chen, Quan, et al.
Publicado: (2018)

A panel consisting of three novel circulating lncRNAs, is it a predictive tool for gastric cancer?
por: Liu, Jingjing, et al.
Publicado: (2018)

A nomogram for predicting bowel obstruction in preoperative colorectal cancer patients with clinical characteristics
por: Lv, Xinger, et al.
Publicado: (2019)

Prognostic value of gastric cancer‐associated gene signatures: Evidence based on a meta‐analysis using integrated bioinformatics methods
por: Wang, Jun, et al.
Publicado: (2018)

tRFTars: predicting the targets of tRNA-derived fragments
por: Xiao, Qiong, et al.
Publicado: (2021)

The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer
por: Song, Yongxi, et al.
Publicado: (2017)

Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer
por: Ma, Bin, et al.
Publicado: (2016)

MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer
por: Shi, Jinxin, et al.
Publicado: (2021)

Efficacy and safety of taxane-based systemic chemotherapy of advanced gastric cancer: A systematic review and meta-analysis
por: Shi, Jinxin, et al.
Publicado: (2017)

The potential adjunctive benefit of adding metformin to standard treatment in inoperable cancer patients: a meta-analysis of randomized controlled trials
por: Wu, Zhonghua, et al.
Publicado: (2020)

Quantitative global proteome and lysine succinylome analyses provide insights into metabolic regulation and lymph node metastasis in gastric cancer
por: Song, Yongxi, et al.
Publicado: (2017)

Prognostic evaluation of platelet to lymphocyte ratio in patients with colorectal cancer
por: Lu, Chong, et al.
Publicado: (2017)

The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta‐analysis
por: Zhong, Xi, et al.
Publicado: (2018)

Screening of Potential Biomarkers for Gastric Cancer with Diagnostic Value Using Label-free Global Proteome Analysis
por: Song, Yongxi, et al.
Publicado: (2020)

The Clinical Significance and Mechanisms of REG4 in Human Cancers
por: Zhang, Junyan, et al.
Publicado: (2021)

Conversion Surgery for Stage IV Gastric Cancer
por: Zhang, Fei, et al.
Publicado: (2019)

Long noncoding RNAs in gastric cancer: functions and clinical applications
por: Wang, Jiajun, et al.
Publicado: (2016)

The Impact of the Expression Level of Intratumoral Dihydropyrimidine Dehydrogenase on Chemotherapy Sensitivity and Survival of Patients in Gastric Cancer: A Meta-Analysis
por: Zhang, Cong, et al.
Publicado: (2017)

The differences on efficacy of oxaliplatin in locally advanced colon cancer between mucinous and nonmucinous adenocarcinoma
por: Yu, Dehao, et al.
Publicado: (2018)

Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis
por: Wu, Pei, et al.
Publicado: (2018)

Circulating tumor DNA sequencing in colorectal cancer patients treated with first-line chemotherapy with anti-EGFR
por: Lim, Yoojoo, et al.
Publicado: (2021)

Efficacy and safety of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer in first-line and second-line therapies: a meta-analysis
por: Wang, Hongchi, et al.
Publicado: (2016)

Prognostic Value of Preoperative Fibrinogen for Predicting Clinical Outcome in Patients with Nonmetastatic Colorectal Cancer
por: Sun, Yu, et al.
Publicado: (2020)

Circulating Tumor DNA as a Novel Biomarker Optimizing Chemotherapy for Colorectal Cancer
por: Osumi, Hiroki, et al.
Publicado: (2020)

Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery
por: Wu, Zhen-Jie, et al.
Publicado: (2018)

Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer
por: Xu, Benling, et al.
Publicado: (2015)

Tumoral cavitation in colorectal cancer patients with unresectable lung metastasis treated with bevacizumab and chemotherapy
por: Peng, Yu, et al.
Publicado: (2018)

Laparoscopic intersphincteric resection versus an open approach for low rectal cancer: a meta-analysis
por: Chen, Hanyu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1qokkfppvfq2i9ckc59eatt4om